Understanding how past COVID-19 vaccinations affect responses to new variants
Official title: Elucidating the impact of immune imprinting on SARS-CoV-2 variant vaccination strategies using a humanized mouse model
Funded at Columbia University Health Sciences · NIH-10785394 · Data updated 2026-11-12
This study is looking at how past COVID-19 vaccinations affect our immune response to newer variants like Omicron BA.4/5, using special mice to understand why some vaccines might not work as well anymore, and it aims to find ways to make vaccines more effective against these changing strains of the virus.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | August 15, 2024 |
| Project end | July 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $193,644 |
| NIH project number | 1K08AI180347-01 |
| Project ID | NIH-10785394 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who have received prior vaccinations against the original SARS-CoV-2 variant and are concerned about their immunity to newer variants.
✕Less likely to help
Patients who have not been vaccinated against any SARS-CoV-2 variants may not benefit from this research.
What this research studies
This research investigates how previous vaccinations against the original SARS-CoV-2 variant influence the immune response to newer variants, particularly focusing on the Omicron BA.4/5 variant. Using a humanized mouse model, the study aims to explore the molecular mechanisms behind immune imprinting, which may limit the effectiveness of updated vaccines. By analyzing antibody responses, the research seeks to identify strategies for improving vaccine efficacy against evolving strains of the virus. This work is crucial for developing better vaccination strategies that can adapt to the ongoing changes in the virus.
Why it matters
Potential benefit: If successful, this research could lead to more effective vaccines that provide better protection against emerging COVID-19 variants.
How similar studies have gone: Previous research has shown that understanding immune responses to viral variants can lead to improved vaccine designs, indicating potential success for this approach.
Where this research is happening
-
Columbia University Health Sciences
New York, United States Active
Researchers
- Principal investigator: Bowen, Anthony — Columbia University Health Sciences
- Study coordinator: Bowen, Anthony
Related research
Other NIH-funded projects on the same topics.
-
How different COVID-19 vaccines shape immune responses
This project compares immune reactions after mRNA and adenoviral COVID-19 vaccines to learn how long protection lasts and why some people get breakthrough infections or side effects.
-
How our immune system keeps a memory of vaccines and infections over time
A long-term study to understand how T cells remember SARS-CoV-2 vaccines and infections, and how this compares with common cold coronaviruses.
-
How lung memory T cells protect you after COVID-19 infection or vaccination
Researchers want to see if immune cells that stay in the lungs after COVID-19 infection or vaccination help protect people from future severe lung illness.
-
COVID-19 vaccine responses in kidney transplant patients taking mycophenolate
This project looks at how the anti-rejection drug mycophenolate affects COVID-19 vaccine protection in people with kidney transplants.
-
Understanding how SARS-CoV-2 vaccines affect immune responses
This study is looking at how well the COVID-19 vaccine and natural infection help your immune system fight the virus, by checking the types of antibodies in your blood and how long they last, so we can better understand protection against COVID-19.
-
Investigating immune responses to COVID-19 vaccination in children with multiple sclerosis on immunotherapy
This study is looking at how different treatments for multiple sclerosis affect how well kids respond to COVID-19 vaccines, so we can better understand how to protect them.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.